IN8BIO, INC. Cash
IN8BIO, INC. (INAB) had Cash of $17.96 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2026-08-06
- 2026-06-30: Cash $17.96M.
- 2026-03-31: Cash $21.94M.
- 2025-12-31: Cash $27.09M.
- 2025-09-30: Cash $10.69M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $17.96M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $21.94M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $27.09M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $10.69M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $13.23M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $11.89M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $11.12M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $4.00M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $10.22M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $13.02M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $21.28M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $12.85M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $16.99M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $10.86M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $18.18M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $27.65M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $25.74M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $32.11M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $37.02M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $40.42M 10-Q · filed 2022-11-10 | $40.67M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $12.00M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $15.05M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $17.99M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |